A patient undergoing radiation therapy for lung cancer reports severe fatigue that is impacting daily activities. The nurse reviews the patient's laboratory results and notes a low hemoglobin level. What is the most appropriate nursing intervention to address the patient's fatigue?

Rationale:

A. Sucralfate does not require refrigeration. Storing it in the refrigerator is unnecessary and may cause the tablets to deteriorate or become difficult to swallow. Proper storage is at room temperature (20–25°C / 68–77°F) in a tightly closed container to protect the medication from moisture and contamination.

B. Taking the tablets whole is crucial because sucralfate’s effectiveness depends on its ability to coat the ulcer site in the stomach and duodenum. Crushing, breaking, or chewing the tablets can disrupt this protective barrier, reducing its ability to adhere to the ulcerated mucosa and protect it from gastric acid and pepsin. This protective coating is what allows ulcers to heal over time, so maintaining the integrity of the tablet is essential for therapeutic effect.

C. Sucralfate should be taken on an empty stomach, typically 1 hour before meals and at bedtime. Taking it only 30 minutes before a meal may reduce its effectiveness, as it may not fully coat the ulcer before exposure to gastric contents. Proper timing allows the medication to form a viscous, adhesive barrier over the ulcer before acid and digestive enzymes are introduced with food.

D. Antacids can interfere with the binding and protective action of sucralfate if taken at the same time. If antacids are needed to relieve symptoms, they should be administered at least 30 minutes before or after sucralfate to prevent interference with ulcer healing.

Rationale:

A. A hiatal hernia does not directly increase the risk of lung disease. While severe or chronic gastroesophageal reflux secondary to a hiatal hernia can lead to aspiration of gastric contents, which may cause cough, asthma-like symptoms, or recurrent pneumonia, these respiratory complications are secondary and occur only in a subset of patients. They are not the primary risk associated with a hiatal hernia and are less relevant for standard patient education.

B. There is no direct causal link between hiatal hernia and stomach cancer. Hiatal hernias involve the displacement of the stomach through the diaphragm, leading primarily to reflux symptoms. Although chronic GERD can contribute to Barrett’s esophagus, a precancerous condition of the esophagus, the hernia itself does not increase gastric malignancy risk. Emphasizing cancer risk could cause unnecessary anxiety.

C. A hiatal hernia significantly increases the risk for gastroesophageal reflux disease (GERD). The anatomical change weakens the lower esophageal sphincter (LES) and allows stomach contents, including acid and bile, to reflux into the esophagus. This can lead to heartburn, regurgitation, esophagitis, chronic cough, and potential Barrett’s esophagus if left untreated. Patient education should focus on dietary and lifestyle modifications as well as weight management, head-of-bed elevation, and adherence to prescribed antacids or proton pump inhibitors. Recognizing and managing GERD symptoms early is essential to prevent long-term esophageal complications.

D. Hiatal hernias are not associated with intestinal cancers. The concern lies within the upper GI tract, particularly the esophagus and stomach, rather than the intestines. Patient education should avoid misleading information that could cause confusion.